4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Propanc Biopharma, Inc. (PPCB) operates in the Biotechnology industry and is headquartered in Camberwell, Australia with about 1 employees. Its market capitalization is roughly $2 million. In the fiscal year ended 2025-06-30, PPCB reported $0M in revenue and ($59M) in net income.
Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia.
Interactive charts & full statements →
| Income statement | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($57M) | ($2M) | ($2M) | ($2M) |
| Net Income | ($59M) | ($2M) | ($3M) | ($3M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($6M) | ($4M) | ($5M) | ($4M) | ($53M) | — |
| Net Income | ($6M) | ($3M) | ($5M) | ($4M) | ($54M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Assets | $20M | $0M | $0M | $0M |
| Total Liabilities | $6M | $4M | $3M | $3M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PPCB viewer.
About TickerBase · Data methodology & sources · Privacy · Terms